RxDoctor Payments Data

Ryan Michels, MD

Orthopaedic Trauma · West Reading, PANPI 1922398957

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,500 of the $13,699 with a category attached, or 69.3%. Si-bone, Inc. accounts for 91.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $7,376 and has fallen 95.9% since, to $303 in 2025.

$13,699in general payments, 2019–2025

Across 41 payments — averaging $334.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$13K
  • Stryker$845
  • Johnson & Johnson$219
  • Medical Device Business Services, Inc.$68
  • Baxter Healthcare$39
$42,174in research payments, 2019–2025

Across 32 payments — averaging $1317.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Si-bone, Inc.$42K

What the payments were for

  • Consulting fees$9,50069%
  • Travel & lodging$1,98214%
  • Food & beverage$2,17816%
  • Other$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,699 in reported general payments places this provider in the 60th percentile of 21 orthopaedic trauma providers in Pennsylvania.

See all orthopaedic trauma providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$384,434
Medicare patients
1,030
Services billed
7,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam111$274
Oxycodone Hcl52$197
Celecoxib19$195
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$78
Tramadol Hcl32$63
Amoxicillin28$62
Tizanidine Hcl14$12

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in West Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →